Legislators in developed countries are loss‐averse and hesitant to make regulatory changes to accommodate new technologies, fearing destruction of a system that works.
No takes yet. Share an insight, caveat, or question.
Arvind Ashta (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: